Aurinia Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $783k | 71k | 11.05 |
| 2025-06-30 | $629k | 74k | 8.47 |
| 2025-03-31 | $674k | 84k | 8.04 |
| 2024-12-31 | $769k | 86k | 8.98 |
| 2024-09-30 | $607k | 83k | 7.33 |
| 2024-06-30 | $473k | 83k | 5.71 |
| 2023-12-31 | $640k | 71k | 8.99 |
| 2023-09-30 | $553k | 71k | 7.77 |
| 2023-06-30 | $689k | 71k | 9.68 |
| 2023-03-31 | $780k | 71k | 10.96 |
| 2022-12-31 | $308k | 71k | 4.32 |
| 2022-09-30 | $535k | 71k | 7.51 |
| 2022-06-30 | $716k | 71k | 10.05 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors